Frontotemporal dementia

May 05, 2020

Target ALS and AFTD Announce $5MM in Grants for Research Targeting Treatments and Biomarkers

Feb 06, 2020

AFTD Welcomes Rosa Canet-Avilés, Ph.D., as Senior Director of Scientific Initiatives

Dec 04, 2019

Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator Announces Second Round of Awards

Nov 21, 2019

Major Research Funding for Blood Test to Accelerate Clinical Trials for New Frontotemporal Degeneration (FTD) Therapies

Nov 18, 2019

Alkermes to Acquire Rodin Therapeutics

Nov 07, 2019

Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases

Oct 24, 2019

Fourth Annual AFTD Benefit Raises More Than $2 Million in Support of Frontotemporal Degeneration Research, Support and Awareness

Jul 09, 2019

Winterlight is developing speech-based digital biomarkers to monitor disease progression in patients with FTD in collaboration with Alector

Oct 23, 2018

Third Annual AFTD Benefit Draws Largest Attendance to Date, Raises over $1.9 Million, in Support of Frontotemporal Degeneration Research, Support and Awareness